Biocon Ltd.

BSE: 532523 | NSE: BIOCON |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE376G01013 | SECTOR: Biotechnology & Medical ResearchBiotechnology & Medical Research

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Biocon Ltd. Biocon Ltd. | BSE 386.15 -6.65 (-1.69%) | NSE 386.30 -6.35 (-1.62%) | Trade | Add

BSE Live

Dec 08, 12:39

386.15 -6.65 (-1.69%)

Volume

AVERAGE VOLUME

5-Day

248,775

10-Day

155,974

30-Day

179,115

175,339

Prev. Close

392.80
Open Price

393.35

Bid Price (Qty.)
386.10 (127)
Offer Price (Qty.)
386.50 (114)

NSE Live

Dec 08, 12:39

386.30 -6.35 (-1.62%)

Volume

AVERAGE VOLUME

5-Day

6,418,711

10-Day

4,162,314

30-Day

4,509,679

4,337,265

Prev. Close

392.65
Open Price

395.20

Bid Price (Qty.)
386.30 (3)
Offer Price (Qty.)
386.40 (197)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Biocon (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	15,052.20	14,195.80	10,934.10	8,184.00	6,970.10
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	15,052.20	14,195.80	10,934.10	8,184.00	6,970.10
Total Operating Revenues	15,261.70	14,755.70	11,174.20	8,184.00	7,105.80
Other Income	1,208.20	865.50	375.90	212.70	254.50
Total Revenue	16,469.90	15,621.20	11,550.10	8,396.70	7,360.30
EXPENSES
Cost Of Materials Consumed	4,276.70	5,071.90	3,191.10	2,813.90	2,430.20
Purchase Of Stock-In Trade	626.60	682.70	626.10	161.10	68.40
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	294.20	-856.70	-154.10	-256.60	-290.10
Employee Benefit Expenses	3,144.40	2,664.10	2,181.00	1,880.10	1,741.00
Finance Costs	897.40	974.40	419.00	67.60	57.70
Depreciation And Amortisation Expenses	1,687.00	1,568.80	1,113.10	814.20	715.10
Other Expenses	3,901.10	3,986.20	3,210.60	2,091.70	1,503.70
Total Expenses	14,679.80	14,000.20	10,194.60	7,095.60	6,226.00
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,790.10	1,621.00	1,355.50	1,301.10	1,134.30
Exceptional Items	96.50	-11.60	-291.40	-111.10	12.60
Profit/Loss Before Tax	1,886.60	1,609.40	1,064.10	1,190.00	1,146.90
Tax Expenses-Continued Operations
Current Tax	369.30	314.30	246.20	220.40	196.60
Less: MAT Credit Entitlement	-55.40	77.40	-98.80	-23.50	25.90
Deferred Tax	32.50	-9.50	-90.90	-32.40	50.80
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	457.20	227.40	254.10	211.50	221.50
Profit/Loss After Tax And Before ExtraOrdinary Items	1,429.40	1,382.00	810.00	978.50	925.40
Profit/Loss From Continuing Operations	1,429.40	1,382.00	810.00	978.50	925.40
Profit/Loss For The Period	1,429.40	1,382.00	810.00	978.50	915.70
Minority Interest	-416.10	-275.30	-180.30	-123.20	-105.70
Consolidated Profit/Loss After MI And Associates	1,013.30	1,022.50	462.70	648.40	740.50
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	8.00	9.00	4.00	5.00	6.00
Diluted EPS (Rs.)	8.00	9.00	4.00	5.00	6.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	60.00	180.10	60.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00